NeuroPace, Inc.
NPCE
$16.36
-$0.14-0.85%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.50M | -8.65M | -6.59M | -5.25M | -5.45M |
| Total Depreciation and Amortization | 487.00K | 477.00K | 462.00K | 451.00K | 451.00K |
| Total Amortization of Deferred Charges | 70.00K | 55.00K | 49.00K | 49.00K | 47.00K |
| Total Other Non-Cash Items | 2.67M | 3.94M | 2.97M | 2.96M | 2.68M |
| Change in Net Operating Assets | -1.67M | 2.09M | -4.37M | -3.00M | 548.00K |
| Cash from Operations | -1.94M | -2.09M | -7.48M | -4.80M | -1.72M |
| Capital Expenditure | -30.00K | -168.00K | -37.00K | -39.00K | -100.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 2.00M | 1.50M |
| Cash from Investing | -30.00K | -168.00K | -37.00K | 1.96M | 1.40M |
| Total Debt Issued | -133.00K | 58.57M | -- | -- | -- |
| Total Debt Repaid | 0.00 | -60.51M | -- | -- | -- |
| Issuance of Common Stock | -- | 205.00K | 70.88M | 940.00K | 2.97M |
| Repurchase of Common Stock | -102.00K | -174.00K | -49.77M | -92.00K | -68.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -235.00K | -1.91M | 21.11M | 848.00K | 2.90M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.21M | -4.16M | 13.59M | -1.99M | 2.57M |